Orexo

red lights

Pharma

Orexo's opioid overdose nasal spray is rejected again by FDA

For the second time in 15 months, the FDA has rejected Orexo’s OX124 (naloxone), a high-dose nasal spray rescue treatment for opioid overdoses.

Kevin Dunleavy Jul 17, 2024 10:47am

Food and Drug Administration

Orexo seeks approval of nasal high-dose opioid rescue medicine

Feb 7, 2023 8:40am

Swedish flag

Orexo unveils nasal EpiPen rival, sets sights on 2022 trial

Dec 7, 2021 10:05am

Orexo Vorvida digital therapeutic social media ad

Orexo backs up new digital therapeutic launches with social

Oct 15, 2020 8:10am